New sedative may offer safer sleep for ICU patients

NCT ID NCT06261996

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested fospropofol against the standard sedative propofol in 200 adults on breathing machines in the ICU. Researchers measured how well each drug kept patients calm and tracked side effects like low blood pressure and injection pain. The goal was to see if fospropofol could be a safer or more effective option for sedation during mechanical ventilation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

fospropofol

What this could lead to

If fospropofol proves safer or more effective than propofol, it could become a preferred sedative for ICU patients on breathing machines.

What could go wrong

This is a small, early-stage study with only 200 participants. Results may not apply to all ICU patients, and side effects like low blood pressure or slow heart rate are possible with both drugs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INVASIVE MECHANICAL VENTILATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Henan Provincial People's Hospital

    Zhengzhou, China